肺炎克雷伯菌
发病机制
微生物学
克雷伯菌
生物
病菌
免疫学
大肠杆菌
基因
遗传学
作者
Jing Li,Qiannan Gao,Yiyangzi Ma,Yue Deng,Shuangyue Li,Na Shi,Haitao Niu,Xin-Yu Liu,Jun Cai
出处
期刊:Hypertension
[Lippincott Williams & Wilkins]
日期:2022-10-19
卷期号:79 (12): 2743-2754
被引量:33
标识
DOI:10.1161/hypertensionaha.122.18878
摘要
Background: Previous studies have reported a strong association between gut microbiome and hypertension; yet, the exact bacterial species associated with the disease development and progression have not yet been detected. This study aimed to investigate whether opportunistic pathogen Klebsiella pneumoniae is a causal factor for hypertension pathogenesis, and explore the potential mechanisms. Methods: The enrichment of Klebsiella pneumoniae in the gut of patients with hypertension was validated by meta-analysis based on 3 independent cohorts. Klebsiella pneumoniae was inoculated into germ-free mice, antibiotic pretreated and conventional mice. Results: Klebsiella pneumoniae led to higher blood pressure, slight cardiac hypertrophy, and enhanced contractility of resistant arteries in recipient mice. Moreover, Klebsiella pneumoniae induced pathological damages, deficiency of tight junction proteins and transcriptional shifts. Metabolic alterations, especially the depletion of stearoylethanolamide, were observed upon Klebsiella pneumoniae administration. In addition, renal transcriptome dysfunction with significant upregulation of genes related to hypertension pathogenesis was observed in Klebsiella pneumoniae treated mice. Conclusions: These results provide evidence that the enrichment of Klebsiella pneumoniae acts as a direct contributor to blood pressure elevation and hypertension pathogenesis, and Klebsiella pneumoniae induced intestinal damages, fecal metabolic changes, and renal shifts may be integrated mediators.
科研通智能强力驱动
Strongly Powered by AbleSci AI